254 related articles for article (PubMed ID: 34522226)
1. Mapping the landscape of synthetic lethal interactions in liver cancer.
Yang C; Guo Y; Qian R; Huang Y; Zhang L; Wang J; Huang X; Liu Z; Qin W; Wang C; Chen H; Ma X; Zhang D
Theranostics; 2021; 11(18):9038-9053. PubMed ID: 34522226
[TBL] [Abstract][Full Text] [Related]
2. Leveraging synthetic lethality to uncover potential therapeutic target in gastric cancer.
Geng H; Qian R; Zhong Y; Tang X; Zhang X; Zhang L; Yang C; Li T; Dong Z; Wang C; Zhang Z; Zhu C
Cancer Gene Ther; 2024 Feb; 31(2):334-348. PubMed ID: 38040871
[TBL] [Abstract][Full Text] [Related]
3. Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction.
Carbajosa S; Pansa MF; Paviolo NS; Castellaro AM; Andino DL; Nigra AD; García IA; Racca AC; Rodriguez-Berdini L; Angiolini V; Guantay L; Villafañez F; Federico MB; Rodríguez-Baili MC; Caputto BL; Drewes G; Madauss KP; Gloger I; Fernandez E; Gil GA; Bocco JL; Gottifredi V; Soria G
Clin Cancer Res; 2019 Jul; 25(13):4049-4062. PubMed ID: 30890549
[TBL] [Abstract][Full Text] [Related]
4. The tumor therapy landscape of synthetic lethality.
Zhang B; Tang C; Yao Y; Chen X; Zhou C; Wei Z; Xing F; Chen L; Cai X; Zhang Z; Sun S; Liu Q
Nat Commun; 2021 Feb; 12(1):1275. PubMed ID: 33627666
[TBL] [Abstract][Full Text] [Related]
5. Ranking novel cancer driving synthetic lethal gene pairs using TCGA data.
Ye H; Zhang X; Chen Y; Liu Q; Wei J
Oncotarget; 2016 Aug; 7(34):55352-55367. PubMed ID: 27438146
[TBL] [Abstract][Full Text] [Related]
6. Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data.
Sinha S; Thomas D; Chan S; Gao Y; Brunen D; Torabi D; Reinisch A; Hernandez D; Chan A; Rankin EB; Bernards R; Majeti R; Dill DL
Nat Commun; 2017 May; 8():15580. PubMed ID: 28561042
[TBL] [Abstract][Full Text] [Related]
7. Link synthetic lethality to drug sensitivity of cancer cells.
Wang R; Han Y; Zhao Z; Yang F; Chen T; Zhou W; Wang X; Qi L; Zhao W; Guo Z; Gu Y
Brief Bioinform; 2019 Jul; 20(4):1295-1307. PubMed ID: 29300844
[TBL] [Abstract][Full Text] [Related]
8. Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality.
Benfatto S; Serçin Ö; Dejure FR; Abdollahi A; Zenke FT; Mardin BR
Mol Cancer; 2021 Aug; 20(1):111. PubMed ID: 34454516
[TBL] [Abstract][Full Text] [Related]
9. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
Srihari S; Singla J; Wong L; Ragan MA
Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
[TBL] [Abstract][Full Text] [Related]
10. A Synthetic Dosage Lethal Genetic Interaction Between CKS1B and PLK1 Is Conserved in Yeast and Human Cancer Cells.
Reid RJ; Du X; Sunjevaric I; Rayannavar V; Dittmar J; Bryant E; Maurer M; Rothstein R
Genetics; 2016 Oct; 204(2):807-819. PubMed ID: 27558135
[TBL] [Abstract][Full Text] [Related]
11. Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality.
Jerby-Arnon L; Pfetzer N; Waldman YY; McGarry L; James D; Shanks E; Seashore-Ludlow B; Weinstock A; Geiger T; Clemons PA; Gottlieb E; Ruppin E
Cell; 2014 Aug; 158(5):1199-1209. PubMed ID: 25171417
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Lethality-based Identification of Targets for Anticancer Drugs in the Human Signaling Network.
Liu L; Chen X; Hu C; Zhang D; Shao Z; Jin Q; Yang J; Xie H; Liu B; Hu M; Ke K
Sci Rep; 2018 May; 8(1):8440. PubMed ID: 29855504
[TBL] [Abstract][Full Text] [Related]
13. A systematic analysis of the landscape of synthetic lethality-driven precision oncology.
Schäffer AA; Chung Y; Kammula AV; Ruppin E; Lee JS
Med; 2024 Jan; 5(1):73-89.e9. PubMed ID: 38218178
[TBL] [Abstract][Full Text] [Related]
14. Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.
Srivatsa S; Montazeri H; Bianco G; Coto-Llerena M; Marinucci M; Ng CKY; Piscuoglio S; Beerenwinkel N
Nat Commun; 2022 Dec; 13(1):7748. PubMed ID: 36517508
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Lethality: From Research to Precision Cancer Nanomedicine.
Gupta A; Ahmad A; Dar AI; Khan R
Curr Cancer Drug Targets; 2018; 18(4):337-346. PubMed ID: 28669337
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic target screening.
Weng S; Ruan H
FEBS J; 2023 Mar; 290(6):1477-1480. PubMed ID: 36461713
[TBL] [Abstract][Full Text] [Related]
17. SL
Liu Y; Wu M; Liu C; Li XL; Zheng J
IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(3):748-757. PubMed ID: 30969932
[TBL] [Abstract][Full Text] [Related]
18. A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism.
Apaolaza I; San José-Enériz E; Valcarcel LV; Agirre X; Prosper F; Planes FJ
PLoS Comput Biol; 2022 Mar; 18(3):e1009395. PubMed ID: 35286311
[TBL] [Abstract][Full Text] [Related]
19. Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls.
Shen JP; Ideker T
J Mol Biol; 2018 Sep; 430(18 Pt A):2900-2912. PubMed ID: 29932943
[TBL] [Abstract][Full Text] [Related]
20. Identification of synthetic lethality based on a functional network by using machine learning algorithms.
Li J; Lu L; Zhang YH; Liu M; Chen L; Huang T; Cai YD
J Cell Biochem; 2019 Jan; 120(1):405-416. PubMed ID: 30125975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
